Eslit, Jesa Mae .

HRN: 27-44-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
METRONIDAZOLE 500MG (TAB)
07/09/2025
07/16/2025
PO
500mg
TID
Thickly Msaf
Remove - Pending Acceptance
07/09/2025
CEFUROXIME 500MG (TAB)
07/09/2025
07/16/2025
PO
500mg
BID
Thickly Msaf
Remove - Pending Acceptance
07/09/2025
CEFUROXIME 1.5GM (VIAL)
07/09/2025
07/15/2025
IV
1.5g
Q8
Nsvd Wbc 38
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: